Life sciences industry calls for better funding for medicine and technology regulator

Medicines Australia

31 January 2023 - The life sciences, health and medicine sectors have come together to call for improved funding of the TGA after the agency flagged increases in costs this year due to unexpected issues such as the regulation of cannabis and nicotine vaping products.

CEO of Medicines Australia, Elizabeth de Somer, said the Federal Budget is an opportunity to demonstrate the value the TGA contributes to the health of every Australian.

Read Medicines Australia press release

Michael Wonder

Posted by:

Michael Wonder